ofa vs fda tirzepatide Faces Law Suit Over Sudden Removal of from Drug Shortage List FDA says shortage of GLP-1

Strength supports a higher resting calorie burn: Muscle is metabolically active tissue, meaning it needs calories to maintain itself

In contrast, Semaglutide GLP-1, which is administered weekly, may initially appear more expensive

In phase 3 clinical trials, patients lost an average of 15 more pounds with tirzepatide than with a placebo and an average of 23 pounds more than the placebo group when they used tirzepatide and insulin

Quick Answer: GLP-1 agonists are not currently approved or recommended for treating alcohol use disorder in the UK, though early research suggests potential effects on alcohol consumption via brain reward pathways